Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Separation, Identification and Characterisation of Acidic Degradation of Ritonavir Under ICH Recommended Stress Condition by HPTLC, MS/TOF

Separation, Identification and Characterisation of Acidic Degradation of Ritonavir Under ICH... AbstractThe current study reports the characterization of degradation product from Ritonavir (RITO) through mass spectrometry and the development of a validated and stability-indicating High performance thin layer chromatographic method for the determination of RITO in the presence of its process-related degradation in bulk drug. Stability study on Ritonavir (RITO) was carried out under hydrolytic condition in acidic, alkaline and peroxide, thermal and photolytic conditions in accordance with International Conference on Harmonization (ICH) guidelines Q1 (R2). The drug was found susceptible for degradation under acidic conditions while in rest of conditions drug were stable. A degradation product (DP) was formed in acidic condition. Chromatographic separation was performed on precoated silica gel 60F254 HPTLC plates using acetonitrile: methanol: water (5:3.5:2.5 v/v) as a mobile phase. A mixture of stressed samples was subjected for IR and MS/TOF studies to obtain functional group and mass spectral data. The data found from precise mass study was first utilized to pattern a complete mass fragmentation pathway of the drug and later it was used for its degradant. Structures were proposed for each fragments based on best possible molecular formula. Acidic degradation of RITO 3((3S, 4R)-3-isopropyl-4-(((S)-2-((methoxycarbonyl) amino)-3-phenylpropyl) amino)-2-oxo-5-phenylpentyl)-1-((2isopropylthiazol-4-yl) methyl)-1-methyluronium was identified. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Analytical Chemistry Letters Taylor & Francis

Separation, Identification and Characterisation of Acidic Degradation of Ritonavir Under ICH Recommended Stress Condition by HPTLC, MS/TOF

Download PDF

Separation, Identification and Characterisation of Acidic Degradation of Ritonavir Under ICH Recommended Stress Condition by HPTLC, MS/TOF

Abstract

AbstractThe current study reports the characterization of degradation product from Ritonavir (RITO) through mass spectrometry and the development of a validated and stability-indicating High performance thin layer chromatographic method for the determination of RITO in the presence of its process-related degradation in bulk drug. Stability study on Ritonavir (RITO) was carried out under hydrolytic condition in acidic, alkaline and peroxide, thermal and photolytic conditions in accordance with...
Loading next page...
 
/lp/taylor-francis/separation-identification-and-characterisation-of-acidic-degradation-VnCSTCiZa5
Publisher
Taylor & Francis
Copyright
© 2016 Har Krishan Bhalla & Sons
ISSN
2230-7532
eISSN
2229-7928
DOI
10.1080/22297928.2016.1196607
Publisher site
See Article on Publisher Site

Abstract

AbstractThe current study reports the characterization of degradation product from Ritonavir (RITO) through mass spectrometry and the development of a validated and stability-indicating High performance thin layer chromatographic method for the determination of RITO in the presence of its process-related degradation in bulk drug. Stability study on Ritonavir (RITO) was carried out under hydrolytic condition in acidic, alkaline and peroxide, thermal and photolytic conditions in accordance with International Conference on Harmonization (ICH) guidelines Q1 (R2). The drug was found susceptible for degradation under acidic conditions while in rest of conditions drug were stable. A degradation product (DP) was formed in acidic condition. Chromatographic separation was performed on precoated silica gel 60F254 HPTLC plates using acetonitrile: methanol: water (5:3.5:2.5 v/v) as a mobile phase. A mixture of stressed samples was subjected for IR and MS/TOF studies to obtain functional group and mass spectral data. The data found from precise mass study was first utilized to pattern a complete mass fragmentation pathway of the drug and later it was used for its degradant. Structures were proposed for each fragments based on best possible molecular formula. Acidic degradation of RITO 3((3S, 4R)-3-isopropyl-4-(((S)-2-((methoxycarbonyl) amino)-3-phenylpropyl) amino)-2-oxo-5-phenylpentyl)-1-((2isopropylthiazol-4-yl) methyl)-1-methyluronium was identified.

Journal

Analytical Chemistry Letters – Taylor & Francis

Published: May 3, 2016

Keywords: Ritonavir; HPTLC; Validation; Degradation pathway

References

  • Determination of atazanavir and other retroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection
  • LC method for studies on the stability of lopinavir and ritonavir in soft gelatin capsules
  • Simultaneous quantitative determination of the HI protease, indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography
  • A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz,tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV
  • A novel LC-ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma
  • HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form
  • Rapid simultaneous determination of lopinavir and ritonavir in human plasma by stacking protein precipitations and salting-out assisted liquid/liquid extraction, and ultrafast LC-MS/MS
  • Determination of saquinavir and ritonavir in human plasma by reversedphase high-performance liquid chromatography and the analytical error function, Journal
  • Quantitative Determination of Lopinavir and Ritonavir in Syrup Preparation by Liquid Chromatography
  • Rapid and Sensitive method for Quantitative Determination of Lopinavir and Ritonavir in Human Plasma by Liquid ChromatographyTandem Mass Spectrometry
  • Micellar electrokinetic chromatography method development for determination of impurities in ritonavir
  • Determination of lopinavir and ritonavir in blood plasma, seminal plasma, saliva and plasma ultra-filtrate by liquid chromatography/tandem mass spectrometry detection
  • Thermal stability and hydration behavior of ritonavir sulfate: A vibrational spectroscopic approach
  • Development and Validation of Analytical method for Lopinavir and Ritonavir by HPLC, International Journal Drug Development
  • Development and validation of spectrophotometric method for quantitative estimation of ritonavir in bulk and pharmaceutical dosage forms
  • Validated Stability-Indicating HPLC and HPTLC Methods for the Determination of Ritonavir in Bulk Powder and in Capsules
  • Separation, Identification, and Characterization of Degradation Products of Erlotinib Hydrochloride Under ICH-Recommended Stress Conditions by LC, LC-MS/TOF